{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:29:34Z","timestamp":1793683774424,"version":"4.5.1"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002385","name":"Ministry of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003008","name":"Ministry of Higher Education, Egypt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ejps.2025.107247","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:14:57Z","timestamp":1756307697000},"page":"107247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Fluoroquinolones as versatile scaffolds: Potential for targeting classical and novel mechanisms to combat antibacterial resistance"],"prefix":"10.1016","volume":"214","author":[{"given":"Ahmed M. Kamal","family":"El-sagheir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0370-7653","authenticated-orcid":false,"given":"Jari","family":"Yli-Kauhaluoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2025.107247_bib0147","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2016.11.002","article-title":"Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives","volume":"70","author":"Abdullah","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0023","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1017\/S0031182016002377","article-title":"Mycobacterial cell wall biosynthesis: A multifaceted antibiotic target","volume":"145","author":"Abrahams","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.ejps.2025.107247_bib0042","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mib.2021.01.012","article-title":"Synthesis and recycling of the mycobacterial cell envelope","volume":"60","author":"Abrahams","year":"2021","journal-title":"Curr. Opin. Microbiol."},{"issue":"25","key":"10.1016\/j.ejps.2025.107247_bib0041","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1074\/jbc.RA118.002597","article-title":"Structural and functional determination of homologs of the Mycobacterium tuberculosis N-acetylglucosamine-6-phosphate deacetylase (NagA)","volume":"293","author":"Ahangar","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.ejps.2025.107247_bib0114","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/j.ejps.2025.107247_bib0024","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1073\/pnas.1525055113","article-title":"Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase","volume":"113","author":"Aldred","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0106","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1166\/mex.2024.2650","article-title":"Fluoroquinolone and enoxacin molecules are potential urease inhibitors for treating ureolytic bacterial infections","volume":"14","author":"Alkhalil","year":"2024","journal-title":"Mater. Express"},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197111","article-title":"The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model","volume":"13","author":"Almagor","year":"2018","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.ejps.2025.107247_bib0068","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: How to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2025.107247_bib0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones","volume":"51","author":"Andersson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"issue":"11","key":"10.1016\/j.ejps.2025.107247_bib0048","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1039\/C4MD00136B","article-title":"Synthesis of a novel series of 2,3,4-trisubstituted oxazolidines designed by isosteric replacement or rigidification of the structure and cytotoxic evaluation","volume":"5","author":"Andrade","year":"2014","journal-title":"MedChemComm"},{"issue":"17","key":"10.1016\/j.ejps.2025.107247_bib0069","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/cmdc.201600180","article-title":"Discovery of new potential anti-infective compounds based on carbonic anhydrase inhibitors by rational target-focused repurposing approaches","volume":"11","author":"Annunziato","year":"2016","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0165","article-title":"Fluoroquinolones: Neurological complications and side effects in clinical practice","volume":"16","author":"Anwar","year":"2024","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0121","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.14615","article-title":"Evaluation of quinoline-related carboxylic acid derivatives as prospective differentially antiproliferative, antioxidative, and anti-Inflammatory agents","volume":"104","author":"Arabiyat","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"issue":"16","key":"10.1016\/j.ejps.2025.107247_bib0116","doi-asserted-by":"crossref","first-page":"9611","DOI":"10.1093\/nar\/gkx649","article-title":"Activities of gyrase and topoisomerase IV on positively supercoiled DNA","volume":"45","author":"Ashley","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0034","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00272-17","article-title":"Targeting energy metabolism in Mycobacterium tuberculosis, a new paradigm in antimycobacterial drug discovery","volume":"8","author":"Bald","year":"2017","journal-title":"mBio"},{"issue":"16","key":"10.1016\/j.ejps.2025.107247_bib0031","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.3390\/app10165704","article-title":"Two decades of TB drug discovery efforts\u2014what have we learned?","volume":"10","author":"Bandodkar","year":"2020","journal-title":"Appl. Sci."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0053","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/138920108783497668","article-title":"Mechanism and inhibition of LpxC: An essential zinc-dependent deacetylase of bacterial lipid A synthesis","volume":"9","author":"Barb","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"24","key":"10.1016\/j.ejps.2025.107247_bib0020","doi-asserted-by":"crossref","first-page":"21633","DOI":"10.1021\/acs.jmedchem.4c02876","article-title":"Move over COVID, tuberculosis is once again the leading cause of death from a single infectious disease","volume":"67","author":"Berida","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0029","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.biopha.2018.04.176","article-title":"Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon","volume":"103","author":"Bhat","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0051","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1530\/REP-17-0406","article-title":"Disruption of female reproductive function by endotoxins","volume":"155","author":"Bidne","year":"2018","journal-title":"Reprod."},{"issue":"12","key":"10.1016\/j.ejps.2025.107247_bib0101","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: An expanded \u201cdiscovery story\u201d","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejps.2025.107247_bib0103","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.3390\/molecules25235662","article-title":"Quinolones: Mechanism, lethality and their contributions to antibiotic resistance","volume":"25","author":"Bush","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107247_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.629163","article-title":"Carbonic anhydrases: New perspectives on protein functional role and inhibition in Helicobacter pylori","volume":"12","author":"Campestre","year":"2021","journal-title":"Front. Microbiol."},{"issue":"18","key":"10.1016\/j.ejps.2025.107247_bib0073","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.2174\/0929867321666141012174921","article-title":"An overview of the selectivity and efficiency of the bacterial carbonic anhydrase inhibitors","volume":"22","author":"Capasso","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0127","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10048","article-title":"Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin","volume":"6","author":"Chan","year":"2015","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0035","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1475-2859-13-S1-S9","article-title":"Cell wall structure and function in lactic acid bacteria","volume":"13","author":"Chapot-Chartier","year":"2014","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.ejps.2025.107247_bib0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.biortech.2016.04.019","article-title":"Biorefineries of carbon dioxide: From carbon capture and storage (CCS) to bioenergies production","volume":"215","author":"Cheah","year":"2016","journal-title":"Bioresour. Technol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12718-4","article-title":"Dissecting the mycobacterial cell envelope and defining the composition of the native mycomembrane","volume":"7","author":"Chiaradia","year":"2017","journal-title":"Sci. Rep."},{"issue":"18","key":"10.1016\/j.ejps.2025.107247_bib0049","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/S0960-894X(02)00510-3","article-title":"Multisubstrate analogue inhibitors of glucosamine-6-phosphate synthase from Candida albicans","volume":"12","author":"Chittur","year":"2002","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"47","key":"10.1016\/j.ejps.2025.107247_bib0063","doi-asserted-by":"crossref","first-page":"34073","DOI":"10.1074\/jbc.M113.513028","article-title":"Structure of the bacterial deacetylase LpxC bound to the nucleotide reaction product reveals mechanisms of oxyanion stabilization and proton transfer","volume":"288","author":"Clayton","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.ejps.2025.107247_bib0142","doi-asserted-by":"crossref","first-page":"6513","DOI":"10.1016\/j.bmcl.2012.05.026","article-title":"Studies on the antimicrobial properties of N-acylated ciprofloxacins","volume":"22","author":"Cormier","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0012","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1469-0691.2009.02737.x","article-title":"Fighting infections due to multidrug-resistant Gram-positive pathogens","volume":"15","author":"Cornaglia","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0122","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1099\/jmm.0.000475","article-title":"Mechanisms of quinolone action and resistance: Where do we stand?","volume":"66","author":"Correia","year":"2017","journal-title":"J. Med. Microbiol."},{"issue":"8","key":"10.1016\/j.ejps.2025.107247_bib0076","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1074\/jbc.M510756200","article-title":"Structural mechanics of the pH-dependent activity of beta-carbonic anhydrase from Mycobacterium tuberculosis","volume":"281","author":"Covarrubias","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"Pt 9","key":"10.1016\/j.ejps.2025.107247_bib0075","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1107\/S0907444900008519","article-title":"Cloning, crystallization and preliminary characterization of a beta-carbonic anhydrase from Escherichia coli","volume":"56","author":"Cronk","year":"2000","journal-title":"Acta Crystallogr., Sect. D: Biol. Crystallogr."},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0078","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1110\/ps.46301","article-title":"Crystal structure of E. coli beta-carbonic anhydrase, an enzyme with an unusual pH-dependent activity","volume":"10","author":"Cronk","year":"2001","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejps.2025.107247_bib0036","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.3389\/fmicb.2019.02051","article-title":"Editorial: Bacterial cell wall structure and dynamics","volume":"10","author":"D\u00f6rr","year":"2019","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.ejps.2025.107247_bib0080","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/molecules25112564","article-title":"Anion inhibition studies of the beta-carbonic anhydrase from Escherichia coli","volume":"25","author":"Del Prete","year":"2020","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejps.2025.107247_bib0027","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/j.bmcl.2016.02.043","article-title":"Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents","volume":"26","author":"Desai","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0011","article-title":"Overview of antimicrobial resistance and mechanisms: The relative status of the past and current","volume":"3","author":"Devi","year":"2024","journal-title":"Microbe"},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0062","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.bmcl.2017.12.005","article-title":"Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents","volume":"28","author":"Ding","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0016","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.1038\/s41598-023-36240-y","article-title":"Extended-spectrum beta-lactamases found in Escherichia coli isolates obtained from blood cultures and corresponding stool specimen","volume":"13","author":"Doerr","year":"2023","journal-title":"Sci. Rep."},{"issue":"suppl 1","key":"10.1016\/j.ejps.2025.107247_bib0015","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1093\/cid\/ciw829","article-title":"Gram-negative bacterial infections: Research priorities, accomplishments, and future directions of the antibacterial resistance leadership group","volume":"64","author":"Doi","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0088","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/CMR.15.2.167-193.2002","article-title":"Biofilms: Survival mechanisms of clinically relevant microorganisms","volume":"15","author":"Donlan","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0117","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14787210.2021.1840353","article-title":"Bacterial death from treatment with fluoroquinolones and other lethal stressors","volume":"19","author":"Drlica","year":"2021","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0119","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1128\/AAC.01617-06","article-title":"Quinolone-mediated bacterial death","volume":"52","author":"Drlica","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0134","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s11030-022-10581-8","article-title":"Quinolone: A versatile therapeutic compound class","volume":"27","author":"Dube","year":"2023","journal-title":"Mol. Diversity"},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0162","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/ph18020184","article-title":"Fluoroquinolone-mediated tendinopathy and tendon rupture","volume":"18","author":"Duman","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"12","key":"10.1016\/j.ejps.2025.107247_bib0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00203-023-03696-5","article-title":"Analysis of random mutations in Salmonella gallinarum dihydropteroate synthase conferring sulfonamide resistance","volume":"205","author":"Duysak","year":"2023","journal-title":"Arch. Microbiol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0017","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12941-024-00761-9","article-title":"Porin expression in clinical isolates of Klebsiella pneumoniae: A comparison of SDS-PAGE and MALDI-TOF\/MS and limitations of whole genome sequencing analysis","volume":"23","author":"El\u00edas-L\u00f3pez","year":"2024","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0130","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1086\/321815","article-title":"Vancomycin-resistant enterococci: Mechanisms and clinical observations","volume":"33","author":"Eliopoulos","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ejps.2025.107247_bib0061","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025304","article-title":"Antibacterial drug discovery targeting the lipopolysaccharide biosynthetic enzyme LpxC","volume":"6","author":"Erwin","year":"2016","journal-title":"Cold Spring Harbor Perspect. Med."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0113","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1751-7915.2008.00063.x","article-title":"Mechanism of action of and resistance to quinolones","volume":"2","author":"F\u00e0brega","year":"2009","journal-title":"Microb. Biotechnol."},{"key":"10.1016\/j.ejps.2025.107247_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115373","article-title":"Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones","volume":"254","author":"Fedorowicz","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jmb.2006.03.024","article-title":"Structural analysis of N-acetylglucosamine-6-phosphate deacetylase apoenzyme from Escherichia coli","volume":"359","author":"Ferreira","year":"2006","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0058","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00939-20","article-title":"An essential membrane protein modulates the proteolysis of LpxC to control lipopolysaccharide synthesis in Escherichia coli","volume":"11","author":"Fivenson","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ejps.2025.107247_bib0138","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejps.2025.107247_bib0083","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400548","article-title":"Cyclization of acyl thiosemicarbazides led to new Helicobacter pylori \u03b1-carbonic anhydrase inhibitors","volume":"357","author":"Gumus","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejps.2025.107247_bib0146","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.12.017","article-title":"Isatin derivatives and their anti-bacterial activities","volume":"164","author":"Guo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejps.2025.107247_bib0163","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/antibiotics11121843","article-title":"The blood\u2013brain barrier and pharmacokinetic\/pharmacodynamic optimization of antibiotics for the treatment of central nervous system infections in adults","volume":"11","author":"Haddad","year":"2022","journal-title":"Antibiotics"},{"issue":"7","key":"10.1016\/j.ejps.2025.107247_bib0087","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1111\/j.1462-5822.2009.01323.x","article-title":"Evolving concepts in biofilm infections","volume":"11","author":"Hall-Stoodley","year":"2009","journal-title":"Cell. Microbiol."},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0094","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrmicro821","article-title":"Bacterial biofilms: From the natural environment to infectious diseases","volume":"2","author":"Hall-Stoodley","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"issue":"11","key":"10.1016\/j.ejps.2025.107247_bib0131","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3855\/jidc.3105","article-title":"Fluoroquinolone resistant mechanisms in methicillin-resistant Staphylococcus aureus clinical isolates in Cairo, Egypt","volume":"7","author":"Hashem","year":"2013","journal-title":"J. Infect. Dev. Countries"},{"key":"10.1016\/j.ejps.2025.107247_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115867","article-title":"Synthetic non-toxic anti-biofilm agents as a strategy in combating bacterial resistance","volume":"262","author":"Hassan","year":"2023","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0019","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.3390\/app10062153","article-title":"Drug-resistant tuberculosis: Where we stand","volume":"10","author":"Iacobino","year":"2020","journal-title":"Appl. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.ejps.2025.107247_bib0133","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1086\/428052","article-title":"Mechanisms of resistance to quinolones","volume":"41","author":"Jacoby","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0007","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/antibiotics10040415","article-title":"Mechanisms of antibiotic resistance in important Gram-positive and Gram-negative pathogens and novel antibiotic solutions","volume":"10","author":"Kakoullis","year":"2021","journal-title":"Antibiotics"},{"issue":"11","key":"10.1016\/j.ejps.2025.107247_bib0054","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/13543776.2017.1360282","article-title":"LpxC inhibitors: A patent review (2010-2016)","volume":"27","author":"Kalinin","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0126","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/acsbiomedchemau.3c00038","article-title":"N4-Substituted piperazinyl norfloxacin derivatives with broad-spectrum activity and multiple mechanisms on gyrase, topoisomerase IV, and bacterial cell wall synthesis","volume":"3","author":"Kamal El-sagheir","year":"2023","journal-title":"ACS Bio Med Chem Au"},{"issue":"12","key":"10.1016\/j.ejps.2025.107247_bib0157","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1039\/D3MD00309D","article-title":"Rational design, synthesis, molecular modeling, biological activity, and mechanism of action of polypharmacological norfloxacin hydroxamic acid derivatives","volume":"14","author":"Kamal El-sagheir","year":"2023","journal-title":"RSC Med. Chem."},{"issue":"45","key":"10.1016\/j.ejps.2025.107247_bib0158","doi-asserted-by":"crossref","first-page":"43271","DOI":"10.1021\/acsomega.3c07221","article-title":"Design, synthesis, molecular modeling, biological activity, and mechanism of action of novel amino acid derivatives of norfloxacin","volume":"8","author":"Kamal El-sagheir","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejps.2025.107247_bib0139","first-page":"92","article-title":"Synthesis, antibacterial and antifungal evaluation of norfloxacin derivatives","volume":"55","author":"Khan","year":"2012","journal-title":"J. Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0166","doi-asserted-by":"crossref","first-page":"dlae127","DOI":"10.1093\/jacamr\/dlae127","article-title":"Navigating fluoroquinolone resistance in Gram-negative bacteria: A comprehensive evaluation","volume":"6","author":"Kherroubi","year":"2024","journal-title":"JAC-Antimicrob. Resist."},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0074","doi-asserted-by":"crossref","first-page":"460","DOI":"10.14348\/molcells.2019.0029","article-title":"Crystal structure of a highly thermostable \u03b1-carbonic anhydrase from Persephonella marina EX-H1","volume":"42","author":"Kim","year":"2019","journal-title":"Mol. Cells"},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0118","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: From targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216029","article-title":"Fluoroquinolone-related adverse events resulting in health service use and costs: A systematic review","volume":"14","author":"Kuula","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0112","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.931","article-title":"Healthcare costs and mortality associated with serious fluoroquinolone-related adverse reactions","volume":"10","author":"Kuula","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0045","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77511-2","article-title":"Naringin derivatives as glucosamine-6-phosphate synthase inhibitors based preservatives and their biological evaluation","volume":"10","author":"Lather","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0047","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13065-021-00769-8","article-title":"Aesculin based glucosamine-6-phosphate synthase inhibitors as novel preservatives for food and pharmaceutical products: In-silico studies, antioxidant, antimicrobial and preservative efficacy evaluation","volume":"15","author":"Lather","year":"2021","journal-title":"BMC Chemistry"},{"issue":"20","key":"10.1016\/j.ejps.2025.107247_bib0064","doi-asserted-by":"crossref","first-page":"9360","DOI":"10.1021\/acs.jmedchem.8b01287","article-title":"Application of virtual screening to the identification of new LpxC inhibitor chemotypes, oxazolidinone and isoxazoline","volume":"61","author":"Lee","year":"2018","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0052","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/nyas.14280","article-title":"Creative targeting of the Gram-negative outer membrane in antibiotic discovery","volume":"1459","author":"MacNair","year":"2020","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0001","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"issue":"21","key":"10.1016\/j.ejps.2025.107247_bib0144","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.3390\/molecules24213959","article-title":"Design, synthesis and biological evaluation of new piperazin-4-yl-(acetyl-thiazolidine-2,4-dione) norfloxacin analogues as antimicrobial agents","volume":"24","author":"Marc","year":"2019","journal-title":"Molecules"},{"issue":"13","key":"10.1016\/j.ejps.2025.107247_bib0108","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s40265-017-0790-5","article-title":"Delafloxacin: First global approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"issue":"16","key":"10.1016\/j.ejps.2025.107247_bib0136","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.3390\/molecules28166018","article-title":"Fluoroquinolone analogs, SAR analysis, and the antimicrobial evaluation of 7-benzimidazol-1-yl-fluoroquinolone in in vitro, in silico, and in vivo models","volume":"28","author":"Medell\u00edn-Luna","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107247_bib0145","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bioorg.2019.01.009","article-title":"Piperazine-azole-fluoroquinolone hybrids: Conventional and microwave irradiated synthesis, biological activity screening and molecular docking studies","volume":"85","author":"Mermer","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"23","key":"10.1016\/j.ejps.2025.107247_bib0104","doi-asserted-by":"crossref","first-page":"7153","DOI":"10.3390\/molecules26237153","article-title":"Biological effects of quinolones: A family of broad-spectrum antimicrobial agents","volume":"26","author":"Millanao","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2025.107247_bib0092","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.micro.55.1.165","article-title":"Quorum sensing in bacteria","volume":"55","author":"Miller","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0050","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01541-16","article-title":"Antibiotic resistance and regulation of the Gram-negative bacterial outer membrane barrier by host innate immune molecules","volume":"7","author":"Miller","year":"2016","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0137","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11030-010-9238-5","article-title":"Quantitative structure\u2013activity relationship study of antitubercular fluoroquinolones","volume":"15","author":"Minovski","year":"2011","journal-title":"Mol. Diversity"},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0059","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1110\/ps.073324108","article-title":"Crystal structure of LpxC from Pseudomonas aeruginosa complexed with the potent BB-78485 inhibitor","volume":"17","author":"Mochalkin","year":"2008","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejps.2025.107247_bib0148","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bioorg.2018.08.031","article-title":"Synthesis, antimicrobial activity and molecular modeling study of 3-(5-amino-(2H)-1,2,4-triazol-3-yl]-naphthyridinones as potential DNA-gyrase inhibitors","volume":"81","author":"Mohamed","year":"2018","journal-title":"Bioorg. Chem."},{"issue":"17","key":"10.1016\/j.ejps.2025.107247_bib0107","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.2174\/0929867325666180214122944","article-title":"Current trends and future directions of fluoroquinolones","volume":"26","author":"Mohammed","year":"2019","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0013","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s40203-024-00297-y","article-title":"Molecular detection of mecA gene from methicillin-resistant Staphylococcus aureus isolated from clinical and environmental samples and its potential inhibition by phytochemicals using in vitro and in silico approach","volume":"13","author":"Mohammed","year":"2025","journal-title":"In Silico Pharmacol."},{"issue":"18","key":"10.1016\/j.ejps.2025.107247_bib0115","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","article-title":"Fluoroquinolone-gyrase-DNA complexes: Two modes of drug binding","volume":"289","author":"Mustaev","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0123","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/molecules21040268","article-title":"The Current case of quinolones: Synthetic approaches and antibacterial Activity","volume":"21","author":"Naeem","year":"2016","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0129","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70535-y","article-title":"Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: A retrospective genomic epidemiology study","volume":"14","author":"Nehru","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0141","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejmech.2004.11.008","article-title":"Benzenesulfonamide analogs of fluoroquinolones. Antibacterial activity and QSAR studies","volume":"40","author":"Nieto","year":"2005","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","article-title":"Multidrug resistance in bacteria","volume":"78","author":"Nikaido","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.ejps.2025.107247_bib0071","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2174\/138161208783877875","article-title":"The alpha and beta classes carbonic anhydrases from Helicobacter pylori as novel drug targets","volume":"14","author":"Nishimori","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0079","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1080\/14756366.2020.1781845","article-title":"Activation studies of the \u03b2-carbonic anhydrases from Escherichia coli with amino acids and amines","volume":"35","author":"Nocentini","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejps.2025.107247_bib0149","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/slct.201800108","article-title":"Synthesis, antibacterial activity and molecular docking of substituted naphthyridines as potential DNA gyrase inhibitors","volume":"3","author":"Omar","year":"2018","journal-title":"ChemistrySelect"},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0151","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000048533","article-title":"Antituberculous activity of norfloxacin mannich bases with isatin derivatives","volume":"47","author":"Pandeya","year":"2001","journal-title":"Chemotherapy"},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0022","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3390\/microorganisms9051074","article-title":"Treatment of multidrug-resistant and extensively drug-resistant tuberculosis in children: The role of bedaquiline and delamanid","volume":"9","author":"Pecora","year":"2021","journal-title":"Microorganisms"},{"issue":"Suppl 3","key":"10.1016\/j.ejps.2025.107247_bib0135","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1086\/321846","article-title":"Quinolone molecular structure-activity relationships: What we have learned about improving antimicrobial activity","volume":"33","author":"Peterson","year":"2001","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ejps.2025.107247_bib0099","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C9MD00120D","article-title":"Quinolone antibiotics","volume":"10","author":"Pham","year":"2019","journal-title":"MedChemComm"},{"issue":"7","key":"10.1016\/j.ejps.2025.107247_bib0084","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1021\/ml500140t","article-title":"Carbonic anhydrase inhibitors: Design, synthesis, and biological evaluation of novel sulfonyl semicarbazide derivatives","volume":"5","author":"Pichake","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0096","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14787210.2020.1750951","article-title":"Alternative approaches to treat bacterial infections: Targeting quorum-sensing","volume":"18","author":"Piewngam","year":"2020","journal-title":"Expert Rev. Anti-Infect. Ther."},{"issue":"15","key":"10.1016\/j.ejps.2025.107247_bib0072","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1016\/j.bmc.2015.05.029","article-title":"Structure and inhibition studies of a type II beta-carbonic anhydrase psCA3 from Pseudomonas aeruginosa","volume":"23","author":"Pinard","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0089","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.15190\/d.2019.13","article-title":"Communication is the key: Biofilms, quorum sensing, formation and prevention","volume":"7","author":"Preda","year":"2019","journal-title":"Discoveries"},{"key":"10.1016\/j.ejps.2025.107247_bib0060","unstructured":"RCSB Protein Data Bank., 2024. Aquifex aeolicus LpxC complex with ACHN-975. Available at: https:\/\/www.rcsb.org\/structure\/6IH0. Accessed on 15 Dec 2024."},{"key":"10.1016\/j.ejps.2025.107247_bib0124","unstructured":"RCSB Protein Data Bank., 2024. Structure of moxifloxacin with Staphylococcus aureus DNA gyrase and DNA. Available at: https:\/\/www.rcsb.org\/structure\/5CDQ. Accessed on 27 Mar 2024."},{"key":"10.1016\/j.ejps.2025.107247_bib0056","unstructured":"RCSB Protein Data Bank., 2025. Co-crystal structure of Pseudomonas aeruginosa LpxC-50432 complex. Available at: https:\/\/www.rcsb.org\/structure\/6MOD. Accessed on 10 Jan 2025."},{"issue":"18","key":"10.1016\/j.ejps.2025.107247_bib0043","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814021","article-title":"Dual-target Mycobacterium tuberculosis inhibition: Insights into the molecular mechanism of antifolate drugs","volume":"24","author":"Ramharack","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2025.107247_bib0125","unstructured":"RCSB Protein Data Bank, 2024. Crystal structure of moxifloxacin, DNA, and Acinetobacter baumannii topoisomerase IV. Available at: https:\/\/www.rcsb.org\/structure\/2XKK. Accessed on 23 Mar 2024."},{"key":"10.1016\/j.ejps.2025.107247_bib0081","unstructured":"RCSB Protein Data Bank, 2025. Crystal structure of E. coli beta carbonic anhydrase. Available at: https:\/\/www.rcsb.org\/structure\/1I6P. Accessed on 17 May 2025."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00253-011-3486-x","article-title":"Peptidoglycan turnover and recycling in Gram-positive bacteria","volume":"92","author":"Reith","year":"2011","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0009","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0120","article-title":"Potential new fluoroquinolone treatments for suspected bacterial keratitis","volume":"7","author":"Rose","year":"2022","journal-title":"BMJ Open Ophthalmol."},{"key":"10.1016\/j.ejps.2025.107247_bib0154","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117439","article-title":"Antibacterial and anti-biofilm activities of new fluoroquinolone derivatives coupled with nitrogen-based heterocycles","volume":"179","author":"Roszkowski","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0111","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/pharmaceutics15030804","article-title":"Overview of side-effects of antibacterial fluoroquinolones: New drugs versus old drugs, a step forward in the safety profile?","volume":"15","author":"Rusu","year":"2023","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.ejps.2025.107247_bib0093","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1128\/AAC.01396-12","article-title":"Identification of small molecules that antagonize diguanylate cyclase enzymes to inhibit biofilm formation","volume":"56","author":"Sambanthamoorthy","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0091","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/089686080702700417","article-title":"Minimum inhibitory concentration versus minimum biofilm eliminating concentration in evaluation of antibiotic sensitivity of enterococci causing peritonitis","volume":"27","author":"Sepandj","year":"2007","journal-title":"Peritoneal Dial. Int."},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0100","first-page":"587","article-title":"Fluoroquinolone antibacterials: A review on chemistry, microbiology and therapeutic prospects","volume":"66","author":"Sharma","year":"2009","journal-title":"Acta. Pol. Pharm."},{"key":"10.1016\/j.ejps.2025.107247_bib0028","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.trsl.2020.03.007","article-title":"New tuberculosis drug targets, their inhibitors, and potential therapeutic impact","volume":"220","author":"Shetye","year":"2020","journal-title":"Transl. Res."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0164","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.3390\/molecules28041762","article-title":"A Comprehensive overview of the antibiotics approved in the last two decades: Retrospects and prospects","volume":"28","author":"Shi","year":"2023","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0021","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3109\/14756366.2014.930454","article-title":"Quinoline and quinolones: Promising scaffolds for future antimycobacterial agents","volume":"30","author":"Singh","year":"2015","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0018","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12866-024-03412-3","article-title":"Comparative genomics of quinolone-resistant Escherichia coli from broilers and humans in Norway","volume":"24","author":"Sletteme\u00e5s","year":"2024","journal-title":"BMC Microbiol."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0044","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1080\/14756366.2022.2096018","article-title":"Inhibitors of glucosamine-6-phosphate synthase as potential antimicrobials or antidiabetics \u2013 synthesis and properties","volume":"37","author":"Stefaniak","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"14","key":"10.1016\/j.ejps.2025.107247_bib0102","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.bmc.2019.05.038","article-title":"Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?","volume":"27","author":"Suaifan","year":"2019","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0098","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004174","article-title":"Selective chemical inhibition of agr quorum sensing in Staphylococcus aureus promotes host defense with minimal impact on resistance","volume":"10","author":"Sully","year":"2014","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.ejps.2025.107247_bib0066","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/metabo7040056","article-title":"An overview of the bacterial carbonic anhydrases","volume":"7","author":"Supuran","year":"2017","journal-title":"Metabolites"},{"issue":"12","key":"10.1016\/j.ejps.2025.107247_bib0067","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543776.2020.1811853","article-title":"Antibacterial carbonic anhydrase inhibitors: An update on the recent literature","volume":"30","author":"Supuran","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0082","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/17460441.2017.1253677","article-title":"Advances in structure-based drug discovery of carbonic anhydrase inhibitors","volume":"12","author":"Supuran","year":"2017","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.ejps.2025.107247_bib0152","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ejmech.2013.10.055","article-title":"Synthesis and evaluation of 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(4-(2-(4-substitutedpiperazin-1-yl)acetyl)piperazin-1-yl)quinoline-3-carboxylic acid derivatives as anti-tubercular and antibacterial agents","volume":"71","author":"Suresh","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102965","article-title":"Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents","volume":"88","author":"T\u00fcre","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/541340","article-title":"Multidrug resistance: An emerging crisis","volume":"2014","author":"Tanwar","year":"2014","journal-title":"Interdiscip. Perspect. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0038","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12879-021-06964-1","article-title":"Clinical characteristics of Gram-negative and Gram-positive bacterial infection in acute cholangitis: A retrospective observational study","volume":"22","author":"Tian","year":"2022","journal-title":"BMC Infect. Dis."},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0090","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1365-2958.2010.07279.x","article-title":"LuxR-type quorum-sensing regulators that are detached from common scents","volume":"77","author":"Tsai","year":"2010","journal-title":"Mol. Microbiol."},{"issue":"12","key":"10.1016\/j.ejps.2025.107247_bib0006","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.jiph.2021.10.020","article-title":"Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects","volume":"14","author":"Uddin","year":"2021","journal-title":"J. Infect. Public Health"},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106449","article-title":"Multi-targeted metallo-ciprofloxacin derivatives rationally designed and developed to overcome antimicrobial resistance","volume":"58","author":"Ude","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0003","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.idc.2016.02.004","article-title":"Multidrug-resistant bacteria in the community: Trends and lessons learned","volume":"30","author":"van Duin","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0005","article-title":"The antibiotic crisis: On the search for novel antibiotics and resistance mechanisms","volume":"17","author":"Van Goethem","year":"2024","journal-title":"Microb. Biotechnol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/antibiotics10050593","article-title":"Bacterial resistance to antimicrobial agents","volume":"10","author":"Varela","year":"2021","journal-title":"Antibiotics"},{"issue":"2","key":"10.1016\/j.ejps.2025.107247_bib0086","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/antibiotics9020059","article-title":"Bacterial biofilm and its role in the pathogenesis of disease","volume":"9","author":"Vestby","year":"2020","journal-title":"Antibiotics"},{"issue":"1","key":"10.1016\/j.ejps.2025.107247_bib0132","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijantimicag.2006.02.013","article-title":"Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria","volume":"28","author":"Vila","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"2341","key":"10.1016\/j.ejps.2025.107247_bib0032","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.3389\/fmicb.2018.02341","article-title":"The mycobacterial cell envelope: A relict from the past or the result of recent evolution?","volume":"9","author":"Vincent","year":"2018","journal-title":"Front. Microbiol."},{"issue":"10","key":"10.1016\/j.ejps.2025.107247_bib0025","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1128\/AAC.00287-09","article-title":"Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB","volume":"53","author":"Von Groll","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"18","key":"10.1016\/j.ejps.2025.107247_bib0143","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1016\/j.bmcl.2012.07.040","article-title":"Synthesis, antimycobacterial and antibacterial activity of ciprofloxacin derivatives containing a N-substituted benzyl moiety","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"14","key":"10.1016\/j.ejps.2025.107247_bib0156","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1016\/j.bmc.2014.05.018","article-title":"Novel 3-arylfuran-2(5H)-one-fluoroquinolone hybrid: Design, synthesis and evaluation as antibacterial agent","volume":"22","author":"Wang","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejps.2025.107247_bib0014","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s40121-023-00881-3","article-title":"Characterization of a tigecycline-, linezolid- and vancomycin-resistant clinical Enteroccoccus faecium isolate, carrying vanA and vanB genes","volume":"12","author":"Wardal","year":"2023","journal-title":"Infect. Dis. Ther."},{"issue":"7","key":"10.1016\/j.ejps.2025.107247_bib0065","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.bmcl.2012.01.140","article-title":"Structure based design of an in vivo active hydroxamic acid inhibitor of P. aeruginosa LpxC","volume":"22","author":"Warmus","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"18","key":"10.1016\/j.ejps.2025.107247_bib0161","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810732","article-title":"New insights into ion channels: Predicting hERG-drug interactions","volume":"23","author":"Wempe","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.ejps.2025.107247_bib0057","doi-asserted-by":"crossref","first-page":"8146","DOI":"10.1073\/pnas.1432990100","article-title":"Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis","volume":"100","author":"Whittington","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ejps.2025.107247_bib0128","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"10.1016\/j.ejps.2025.107247_bib0046","doi-asserted-by":"crossref","first-page":"647","DOI":"10.18388\/abp.2005_3425","article-title":"Glucosamine-6-phosphate synthase, a novel target for antifungal agents. Molecular modelling studies in drug design","volume":"52","author":"Wojciechowski","year":"2005","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.ejps.2025.107247_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107938","article-title":"Copper(II) aromatic heterocyclic complexes of gatifloxacin with multi-targeting capabilities for antibacterial therapy and combating antibiotic resistance","volume":"153","author":"Wu","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejmech.2014.04.037","article-title":"Design, synthesis, and evaluation of novel fluoroquinolone-flavonoid hybrids as potent antibiotics against drug-resistant microorganisms","volume":"80","author":"Xiao","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0109","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1435923","article-title":"Psychiatric disorders associated with fluoroquinolones: A pharmacovigilance analysis of the FDA adverse event reporting system database","volume":"15","author":"Xie","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejps.2025.107247_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018099","article-title":"N-Acetylglucosamine 6-phosphate deacetylase (NagA) is required for N-acetyl glucosamine assimilation in Gluconacetobacter xylinus","volume":"6","author":"Yadav","year":"2011","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0030","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02189-19","article-title":"Bacterial longevity requires protein synthesis and a stringent response","volume":"10","author":"Yin","year":"2019","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.ejps.2025.107247_bib0140","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1016\/j.ejmech.2009.05.028","article-title":"Design, synthesis and in vitro antibacterial\/antifungal evaluation of novel 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)quinoline-3-carboxylic acid derivatives","volume":"44","author":"Yu","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2025.107247_bib0026","article-title":"The progress of Mycobacterium tuberculosis drug targets","volume":"11","author":"Zhang","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.ejps.2025.107247_bib0095","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1137947","article-title":"Understanding bacterial biofilms: From definition to treatment strategies","volume":"13","author":"Zhao","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"5","key":"10.1016\/j.ejps.2025.107247_bib0055","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/ijms18050761","article-title":"3D-QSAR, molecular docking and molecular dynamics simulation of Pseudomonas aeruginosa LpxC inhibitors","volume":"18","author":"Zuo","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725002453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:44:21Z","timestamp":1767800661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725002453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":166,"alternative-id":["S0928098725002453"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107247","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoroquinolones as versatile scaffolds: Potential for targeting classical and novel mechanisms to combat antibacterial resistance","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107247","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107247"}}